Scarica l'app Stockscreener
1.815
4.47%
-0.085
Dopo l'orario di chiusura:
1.82
0.005
+0.28%
Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Sees Large Growth in Short Interest - MarketBeat
Ironwood Pharmaceuticals Sets Key Date for 2024 Financial ResultsHere's When to Tune In - StockTitan
Ironwood Pharmaceuticals Inc (IRWD): A New Perspective - Stocks Register
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
FY2025 Earnings Forecast for IRWD Issued By Zacks Research - MarketBeat
IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls - MSN
Zacks Research Issues Negative Forecast for IRWD Earnings - MarketBeat
What is Zacks Research’s Estimate for IRWD FY2025 Earnings? - Defense World
Michael Shetzline Sells 41,269 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Stock - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) CEO Sells $244,752.64 in Stock - MarketBeat
Ironwood Pharmaceuticals (IRWD) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Insider Selling: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Insider Sells 12,048 Shares of Stock - MarketBeat
IRONWOOD PHARMACEUTICALS Earnings Preview: Recent $IRWD Insider Trading, Hedge Fund Activity, and More - Nasdaq
Ironwood Pharmaceuticals CEO Thomas A. McCourt sells $244,752 in stock - MSN
Zacks Research Issues Negative Outlook for IRWD Earnings - Defense World
11,869 Shares in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Acquired by SG Americas Securities LLC - Defense World
Ironwood Pharmaceuticals' principal accounting officer sells $21,204 in stock - MSN
Ironwood Pharmaceuticals' principal accounting officer sells $21,204 in stock By Investing.com - Investing.com Australia
Ironwood Pharmaceuticals CEO Thomas A. McCourt sells $244,752 in stock By Investing.com - Investing.com Australia
Ironwood Pharmaceuticals CFO sells shares worth $21,211 - MSN
Ironwood Pharmaceuticals chief legal officer sells shares worth $68,530 - MSN
Ironwood Pharmaceuticals chief legal officer sells shares worth $68,530 By Investing.com - Investing.com Nigeria
Ironwood Pharmaceuticals SVP sells shares worth $72,633 By Investing.com - Investing.com Australia
Ironwood Pharmaceuticals CFO sells shares worth $21,211 By Investing.com - Investing.com Australia
Ironwood Pharmaceuticals (IRWD) to Release Earnings on Thursday - Defense World
Ironwood Pharmaceuticals’ principal accounting officer sells $21,204 in stock By Investing.com - Investing.com Nigeria
Ironwood Pharmaceuticals Executives Sell Shares for Tax Obligations - TradingView
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Could See Prices Soar In The Coming Months - Marketing Sentinel
Financial Health Report: Ironwood Pharmaceuticals Inc (IRWD)’s Ratios Tell a Tale - The Dwinnex
IRWD’s Stock Market Adventure: -61.63% YTD Growth Amidst Volatility - The InvestChronicle
Should You Invest in Ironwood Pharmaceuticals Inc (IRWD) Now? - The News Heater
Ironwood Pharmaceuticals stock falls as it exits S&P SmallCap 600 - MSN
Analysts Say Ironwood Pharmaceuticals Inc Can Reach $7 In 12 Months - Marketing Sentinel
Ironwood Pharmaceuticals Inc [IRWD] Stock trading around $1.94 per share: What’s Next? - The DBT News
Research Analysts Set Expectations for IRWD Q1 Earnings - MarketBeat
IRWD Shares Experience Decline in Value - Knox Daily
Ironwood Pharmaceuticals stock falls as it exits S&P SmallCap 600 By Investing.com - Investing.com Canada
STATE STREET CORP Reduces Stake in Ironwood Pharmaceuticals Inc - GuruFocus.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Reaches New 1-Year Low Following Analyst Downgrade - MarketBeat
3.23%
3.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):